N-Able, Inc. (NABL) Stock Price & Analysis

N-Able, Inc. (NABL) fell 7.18% to USD 3.23 as of June 10, 2026 at 02:27 UTC, according to Nexqual real-time market data.

NABL last closed at USD 3.48; the session ranged USD 3.22–3.47 on volume of 2,014,629 shares. Market capitalization is $608.46M, with a 52-week range of USD 3.22–9.04 (NYQ). Source: Nexqual, June 10, 2026 at 02:27 UTC.

Key Statistics (as of June 10, 2026 at 02:27 UTC)

PriceUSD 3.23
Change▼ 7.18% (down)
Previous CloseUSD 3.48
OpenUSD 3.47
Day RangeUSD 3.22 – 3.47
52-Week RangeUSD 3.22 – 9.04
Volume2,014,629 shares
Market Cap$608.46M
ExchangeNYQ

Technical Analysis (NABL)

Nexqual's technical model rates NABL "SELL" based on 1 bullish and 5 bearish signals across 124 daily candles, as of June 10, 2026 at 02:27 UTC.

Overall SignalSELL
RSI (14)33.66 (neutral)
vs SMA50Below (USD 4.44)
MACD-0.25 (negative)

Analyst Ratings (NABL)

Wall Street analysts rate NABL "None" based on 5 analysts, with a mean price target of USD 6.85 (range USD 5.75–10), per Nexqual as of June 10, 2026 at 02:27 UTC.

Consensus RatingNone
Analyst Count5
Mean TargetUSD 6.85
High TargetUSD 10
Low TargetUSD 5.75
Buy / Hold / Sell3 / 2 / 1

Earnings (NABL)

Next Earnings Date2026-08-06
EPS EstimateUSD 0.1
Revenue Estimate$137.95M

Recent Earnings History

QuarterActual vs Estimate
2026-03-31USD 0.09 vs est 0.09 ▲ beat
2025-12-31USD 0.06 vs est 0.1 ▼ miss
2025-09-30USD 0.13 vs est 0.09 ▲ beat
2025-06-30USD 0.11 vs est 0.09 ▲ beat

Source: Nexqual, June 10, 2026 at 02:27 UTC.

Financials & Fundamentals (NABL)

Total Revenue$526.91M
Revenue Growth (YoY)+13.10%
Gross Margin+80.23%
Operating Margin+9.84%
Profit Margin-1.99%
ROE-1.33%
Debt / Equity54.54
Current Ratio1.26
Total Cash$117.81M
Total Debt$435.66M
Free Cash Flow$81.07M

Source: Nexqual, June 10, 2026 at 02:27 UTC.

Financial Health Score (NABL)

Nexqual rates N-Able, Inc.'s overall financial health "Solid" across five dimensions, as of June 10, 2026 at 02:27 UTC.

GrowthSolid — Revenue +10% YoY (annual)
ProfitabilityStrong — Gross margin 80%, operating 10%
Balance SheetSolid — $118M cash vs $436M debt
Cash FlowStrong — FCF $81M, 16% margin
EfficiencyCritical — ROE -1%, ROA 2.0%

Ownership (NABL)

Insider Ownership+2.07%
Institutional Ownership+100.16%
Shares Outstanding188.38M
Float73.14M
Short % of Float+4.33%

Source: Nexqual, June 10, 2026 at 02:27 UTC.

Leadership (NABL)

N-Able, Inc. is led by John Pagliuca (age 48), CEO, President & Director, per Nexqual as of June 10, 2026 at 02:27 UTC.

CEO, President & DirectorJohn Pagliuca (age 48)
Executive VP & CFOTimothy James O'Brien (age 38)
Executive VP and Chief Technology & Product OfficerMichael Adler (age 52)
Executive VP & Chief Revenue OfficerFrank Colletti (age 51)
Senior VP & Chief Marketing OfficerVikram Ramesh

Major Backers & Investors (NABL)

Notable institutional backers of N-Able, Inc. include Silver Lake Group, LLC, Thoma Bravo, LP, Nomura Asset Management International Inc, according to Nexqual as of June 10, 2026 at 02:27 UTC.

Active Investors

InvestorStake
Silver Lake Group, LLC32.63%
Thoma Bravo, LP26.59%
Nomura Asset Management International Inc2.27%
Delaware Group Equity Funds V-Nomura Small Cap Value Fund1.49%
AlpInvest Partners B.V.1.27%
ArrowMark Colorado Holdings LLC1.12%

Index Funds (Passive)

FundStake
BlackRock9.97%
Vanguard Group9.21%
Dimensional Fund Advisors2.53%
State Street2.08%

Source: Nexqual, June 10, 2026 at 02:27 UTC.

From N-Able, Inc.'s Latest SEC 10-K Filing (filed 2026-02-26)

Key Strengths & Strategy (as disclosed to the SEC)

Partnerships

Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.

Peers & Related Stocks

SymbolNamePriceChange
EVCMEverCommerce Inc.USD 9▼ 2.17%
CLVTClarivate PlcUSD 2.38▼ 1.24%
CWANClearwater Analytics Holdings, USD 24.35▼ 0.08%
FLYWFlywire Corporation - VotingUSD 14.13▼ 1.87%
LAWCS Disco, Inc.USD 3.56▼ 5.57%

Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 02:27 UTC. This page is informational and not investment advice.